Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).

Two men aged 19 and 21 years ingested 1 g and 4 g respectively from 3 kg of a white crystalline powder that they thought was a substance of abuse. It was later identified as almost pure arsenic trioxide. Both had nausea and vomiting and one developed acute renal failure. Each was treated with 2,3-di...

Full description

Bibliographic Details
Main Authors: Moore, D, O'Callaghan, C, Berlyne, G, Ogg, C, Davies, H, House, I, Henry, J
Format: Journal article
Language:English
Published: 1994
_version_ 1797051779073966080
author Moore, D
O'Callaghan, C
Berlyne, G
Ogg, C
Davies, H
House, I
Henry, J
author_facet Moore, D
O'Callaghan, C
Berlyne, G
Ogg, C
Davies, H
House, I
Henry, J
author_sort Moore, D
collection OXFORD
description Two men aged 19 and 21 years ingested 1 g and 4 g respectively from 3 kg of a white crystalline powder that they thought was a substance of abuse. It was later identified as almost pure arsenic trioxide. Both had nausea and vomiting and one developed acute renal failure. Each was treated with 2,3-dimercaptopropanesulphonate (DMPS), and made a full recovery with no evidence of prolonged renal or neurological impairment. The DMPS-arsenic complex is probably associated with lower penetration into the CNS and as a consequence treatment with DMPS may result in lower acute and chronic neurotoxicity than treatment with the currently standard recommended chelating agent dimercaprol (British Anti-Lewisite; BAL).
first_indexed 2024-03-06T18:24:16Z
format Journal article
id oxford-uuid:0765ddd0-8109-4ce7-bea0-7404a7b9e284
institution University of Oxford
language English
last_indexed 2024-03-06T18:24:16Z
publishDate 1994
record_format dspace
spelling oxford-uuid:0765ddd0-8109-4ce7-bea0-7404a7b9e2842022-03-26T09:07:18ZAcute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0765ddd0-8109-4ce7-bea0-7404a7b9e284EnglishSymplectic Elements at Oxford1994Moore, DO'Callaghan, CBerlyne, GOgg, CDavies, HHouse, IHenry, JTwo men aged 19 and 21 years ingested 1 g and 4 g respectively from 3 kg of a white crystalline powder that they thought was a substance of abuse. It was later identified as almost pure arsenic trioxide. Both had nausea and vomiting and one developed acute renal failure. Each was treated with 2,3-dimercaptopropanesulphonate (DMPS), and made a full recovery with no evidence of prolonged renal or neurological impairment. The DMPS-arsenic complex is probably associated with lower penetration into the CNS and as a consequence treatment with DMPS may result in lower acute and chronic neurotoxicity than treatment with the currently standard recommended chelating agent dimercaprol (British Anti-Lewisite; BAL).
spellingShingle Moore, D
O'Callaghan, C
Berlyne, G
Ogg, C
Davies, H
House, I
Henry, J
Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).
title Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).
title_full Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).
title_fullStr Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).
title_full_unstemmed Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).
title_short Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).
title_sort acute arsenic poisoning absence of polyneuropathy after treatment with 2 3 dimercaptopropanesulphonate dmps
work_keys_str_mv AT moored acutearsenicpoisoningabsenceofpolyneuropathyaftertreatmentwith23dimercaptopropanesulphonatedmps
AT ocallaghanc acutearsenicpoisoningabsenceofpolyneuropathyaftertreatmentwith23dimercaptopropanesulphonatedmps
AT berlyneg acutearsenicpoisoningabsenceofpolyneuropathyaftertreatmentwith23dimercaptopropanesulphonatedmps
AT oggc acutearsenicpoisoningabsenceofpolyneuropathyaftertreatmentwith23dimercaptopropanesulphonatedmps
AT daviesh acutearsenicpoisoningabsenceofpolyneuropathyaftertreatmentwith23dimercaptopropanesulphonatedmps
AT housei acutearsenicpoisoningabsenceofpolyneuropathyaftertreatmentwith23dimercaptopropanesulphonatedmps
AT henryj acutearsenicpoisoningabsenceofpolyneuropathyaftertreatmentwith23dimercaptopropanesulphonatedmps